JOYY Q4 2025 Earnings EPS Misses Estimates Shares Decline 287 ITP Q3 2025 Earnings Narrowing Losses Amidst Challenging Market Conditions CHRD Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency FRO Q1 2026 Earnings EPS Beats Estimates by 572 as Stock Declines Marker Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Progresses CVV Q1 2026 Earnings Narrowing Losses as Operational Efficiencies Begin to Emerge